个性化副甲状腺激素治疗缺甲状腺症:从药理动力学-药理动力学建模的见解
Maira Visscher1,2, Manon Schuls-Fouchier1, Annika M A Berends3
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
持续的副甲状腺激素 (PTH) 输液可以改善低副甲状腺症的酸盐控制,与每日注射不同. 这项研究模拟了PTH的影响,以评估持续与间歇剂量对减少结石风险的评估.
科学领域:
- 内分泌学 在内分泌学.
- 药理动力学和药理动力学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 慢性原发性甲状腺缺血症可以在甲状腺切除术后发展,导致诸如结石病等并发症.
- 通过每天服用一次的副甲状腺激素 (PTH) 标准治疗不足以减少尿路分泌,未能减轻甲状腺的风险.
- 需要采用替代的PTH给药策略,以改善平衡,减少结石的形成.
研究的目的:
- 为了研究连续副甲状腺激素 (PTH) 给药与间歇剂量相比,在管理低副甲状腺症时的疗效.
- 构建一个药理动力学-药理动力学 (PKPD) 模型,以评估不同PTH剂量方案对尿路和酸盐分泌的影响.
- 为了确定连续的PTH输液是否可以更有效地降低尿路分泌量并降低质病风险.
主要方法:
- 一个患有慢性原发性副甲状腺功能障碍症的患者接受了间歇性和持续性输注重组合人副甲状腺激素 (rhPTH[1-84]) 的治疗.
- 在整个治疗期间,血和尿液中的PTH,和酸盐水平都被仔细监测.
- 使用Edsim++开发了一个单间PKPD模型,以分析PTH水平与和酸盐的清除之间的关系.
主要成果:
- 在PKPD模型中,PTH对酸盐清除有显著的影响,对清除的影响不那么明显.
- 与相比,酸盐平衡受同时服用药物的影响较小,使酸盐清除成为更可靠的效果参数 (EC50 = 6.3 pmol/L PTH).
- 持续的PTH输液导致酸盐清除持续增加.
结论:
- 开发的PKPD模型,利用来自各种PTH剂量方案的独特患者数据,包括连续输液,为PTH药理学提供了宝贵的见解.
- 持续服用PTH似乎通过永久增强酸盐清除,提供持续的益处.
- 需要对连续PTH输液进行进一步的研究,以评估其在改善低甲状腺症管理和预防甲病方面的潜力.
更多相关视频
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
相关概念视频
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
